,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,13,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,17,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
8,19,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
9,21,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
10,23,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
11,25,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
12,27,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
13,29,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
14,31,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
15,33,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
16,35,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
17,37,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
18,39,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
19,45,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
20,47,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
21,49,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
22,51,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
23,53,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
24,55,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
25,57,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
26,59,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
27,61,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
28,63,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
29,65,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
30,67,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
31,69,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
32,71,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
33,73,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
34,75,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
35,77,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
36,79,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
37,81,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
38,101,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
39,103,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
40,105,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
41,107,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
42,113,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
43,115,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
44,119,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
45,121,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
46,123,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
47,125,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
48,131,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
49,133,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
50,135,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
51,137,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
52,139,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
53,143,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
54,145,1,1,,538591,11057,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
55,155,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
56,157,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
57,161,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
58,165,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
59,167,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
60,175,1,1,,538591,11057,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
61,179,1,1,,538591,11057,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
62,248,1,1,,538591,11057,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
63,328,1,1,,538591,11057,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
64,330,1,1,,538591,11057,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
65,421,1,3,,17389869,11057,Active,,,,,Cell Viability - BJ,Confirmatory,,
66,426,1,2,,17389869,11057,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
67,427,1,1,,17389869,11057,Active,,,,,Cell Viability - Hek293,Confirmatory,,
68,433,1,1,,17389869,11057,Active,,,,,Cell Viability - HepG2,Confirmatory,,
69,434,1,2,,17389869,11057,Active,,,,,Cell Viability - MRC5,Confirmatory,,
70,435,1,2,,17389869,11057,Active,,,,,Cell Viability - SK-N-SH,Confirmatory,,
71,445,3,1,,17389869,11057,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
72,530,1,1,,17389869,11057,Active,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
73,540,1,1,,17389869,11057,Active,,,,,Cell Viability - N2a,Confirmatory,,
74,541,1,1,,17389869,11057,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
75,542,1,1,,17389869,11057,Active,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
76,543,1,1,,17389869,11057,Active,,,,,Cell Viability - H-4-II-E,Confirmatory,,
77,544,2,1,,17389869,11057,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
78,545,1,1,,17389869,11057,Active,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
79,546,1,1,,17389869,11057,Active,,,,,Cell Viability - Mesenchymal,Confirmatory,,
80,584,1,3,,17389869,11057,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
81,585,1,4,,17389869,11057,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
82,595,1,3,,17389869,11057,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
83,596,1,2,,17389869,11057,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
84,603,1,2,,17389869,11057,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
85,605,1,2,,17389869,11057,Active,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
86,654,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
87,655,1,1,,17389869,11057,Inconclusive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
88,656,1,1,,17389869,11057,Inconclusive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
89,657,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
90,658,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
91,659,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
92,660,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
93,661,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
94,662,1,1,,17389869,11057,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
95,663,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
96,664,1,1,,17389869,11057,Inconclusive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
97,665,1,1,,17389869,11057,Inconclusive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
98,666,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
99,667,1,1,,17389869,11057,Active,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
100,875,1,2,,17389869,11057,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
101,875,1,2,,26748060,11057,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
102,880,2,1,,17389869,11057,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
103,880,2,1,,17389869,11057,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
104,880,2,1,,26748060,11057,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
105,880,2,1,,26748060,11057,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
106,881,2,2,,17389869,11057,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
107,881,2,2,,26748060,11057,Inconclusive,317373425.0,247.0,39.8107,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
108,884,1,2,,17389869,11057,Inconclusive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
109,884,1,2,,26748060,11057,Active,13435386.0,1576.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
110,885,1,2,,17389869,11057,Inactive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
111,885,1,2,,26748060,11057,Inactive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
112,886,1,2,,17389869,11057,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
113,886,1,2,,17389869,11057,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
114,887,1,2,,17389869,11057,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
115,887,1,2,,26748060,11057,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
116,889,1,3,,17389869,11057,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
117,889,1,3,,26748060,11057,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
118,892,1,2,,17389869,11057,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
119,892,1,2,,26748060,11057,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
120,893,1,2,,17389869,11057,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
121,893,1,2,,17389869,11057,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
122,893,1,2,,26748060,11057,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
123,893,1,2,,26748060,11057,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
124,894,2,1,,17389869,11057,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
125,894,2,1,,26748060,11057,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
126,900,1,3,,17389869,11057,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
127,900,1,3,,26748060,11057,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
128,902,1,2,,17389869,11057,Inconclusive,120407068.0,7157.0,10.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
129,902,1,2,,26748060,11057,Inconclusive,120407068.0,7157.0,3.1623,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
130,910,1,2,,26748060,11057,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
131,911,1,1,,17389869,11057,Active,92096784.0,4137.0,0.18,Potency,Tau ThS binding assay,Confirmatory,,
132,912,1,2,,17389869,11057,Inconclusive,21392848.0,,10.0,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
133,921,1,2,,17389869,11057,Active,,,1.2589,Potency,Cell Viability - LYMP2-001,Confirmatory,,
134,923,1,2,,17389869,11057,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
135,923,1,2,,26748060,11057,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
136,924,1,2,,17389869,11057,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
137,924,1,2,,26748060,11057,Inconclusive,120407068.0,7157.0,12.5893,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
138,925,1,2,,17389869,11057,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
139,926,1,2,,17389869,11057,Inconclusive,38016895.0,7253.0,19.9526,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
140,927,1,3,,26748060,11057,Active,188528692.0,9099.0,10.0,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
141,930,1,2,,26748060,11057,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
142,937,1,1,,17389869,11057,Active,46242542.0,6622.0,0.15146099999999998,Potency,Alpha-synuclein ThS binding assay,Confirmatory,,
143,938,1,2,,17389869,11057,Inactive,38016895.0,7253.0,19.9526,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
144,940,1,2,,26611757,11057,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
145,946,1,2,,17389869,11057,Active,,,12.5893,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
146,947,1,2,,17389869,11057,Active,,,25.1189,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
147,948,1,2,,17389869,11057,Active,,,6.3096,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
148,955,1,2,,17389869,11057,Active,,,10.0,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
149,956,1,1,,17389869,11057,Active,257056.0,,0.15,Potency,Beta amyloid ThS binding assay,Confirmatory,,
150,960,1,2,,17389869,11057,Active,,,3.9811,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
151,961,1,2,,17389869,11057,Active,,,10.0,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
152,962,1,2,,17389869,11057,Active,,,15.8489,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
153,963,1,2,,17389869,11057,Active,,,7.9433,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
154,964,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
155,965,1,2,,17389869,11057,Active,,,3.1623,Potency,Cell Viability - LYMP2-003,Confirmatory,,
156,966,1,2,,17389869,11057,Active,,,1.5849,Potency,Cell Viability - LYMP2-004,Confirmatory,,
157,967,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-005,Confirmatory,,
158,968,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-009,Confirmatory,,
159,969,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-011,Confirmatory,,
160,970,1,2,,17389869,11057,Active,,,3.9811,Potency,Cell Viability - LYMP2-013,Confirmatory,,
161,971,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-015,Confirmatory,,
162,972,1,2,,17389869,11057,Active,,,3.9811,Potency,Cell Viability - LYMP2-017,Confirmatory,,
163,973,1,2,,17389869,11057,Active,,,3.1623,Potency,Cell Viability - LYMP2-019,Confirmatory,,
164,974,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-021,Confirmatory,,
165,975,1,2,,17389869,11057,Active,,,3.1623,Potency,Cell Viability - LYMP2-023,Confirmatory,,
166,976,1,2,,17389869,11057,Active,,,6.3096,Potency,Cell Viability - LYMP2-025,Confirmatory,,
167,977,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-002,Confirmatory,,
168,978,1,2,,17389869,11057,Active,,,3.1623,Potency,Cell Viability - LYMP2-006,Confirmatory,,
169,979,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-007,Confirmatory,,
170,980,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-008,Confirmatory,,
171,981,1,2,,17389869,11057,Active,,,1.2589,Potency,Cell Viability - LYMP2-010,Confirmatory,,
172,982,1,2,,17389869,11057,Active,,,1.0,Potency,Cell Viability - LYMP2-012,Confirmatory,,
173,983,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-014,Confirmatory,,
174,984,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-016,Confirmatory,,
175,985,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-018,Confirmatory,,
176,986,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-020,Confirmatory,,
177,987,1,2,,17389869,11057,Active,,,0.7943,Potency,Cell Viability - LYMP2-022,Confirmatory,,
178,988,1,2,,17389869,11057,Active,,,1.9953,Potency,Cell Viability - LYMP2-024,Confirmatory,,
179,989,1,2,,17389869,11057,Active,,,2.5119,Potency,Cell Viability - LYMP2-026,Confirmatory,,
180,991,1,1,,17389869,11057,Active,92096784.0,4137.0,0.72,2nd Test Concentration,Tau Fibrillization assay,Confirmatory,,
181,993,1,2,,17389869,11057,Active,,,3.1623,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
182,994,1,2,,17389869,11057,Active,,,3.9811,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
183,995,1,2,,17389869,11057,Active,66932916.0,5594.0,1.9953,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
184,995,1,2,,26748060,11057,Active,66932916.0,5594.0,10.0,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
185,1030,2,1,,17389869,11057,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
186,1030,2,1,,26748060,11057,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
187,1189,1,5,,48413809,11057,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
188,1194,1,3,,48413809,11057,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
189,1199,1,3,,48413809,11057,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
190,1205,1,4,,48413809,11057,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
191,1379,1,2,,26748060,11057,Active,1669525.0,,5.0119,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
192,1422,1,1,,26611757,11057,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
193,1452,1,1,,17389869,11057,Inconclusive,154426292.0,239.0,31.6228,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
194,1452,1,1,,26748060,11057,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
195,1454,1,1,,26748060,11057,Active,66932916.0,5594.0,12.5893,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
196,1457,1,1,,17389869,11057,Inactive,44888968.0,83523.0,12.5893,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
197,1457,1,1,,26748060,11057,Inactive,44888968.0,83523.0,10.0,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
198,1458,1,1,,17389869,11057,Inactive,10937869.0,6607.0,4.4668,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
199,1458,1,1,,26748060,11057,Inactive,10937869.0,6607.0,2.2387,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
200,1460,1,3,,26748060,11057,Active,92096784.0,4137.0,5.0119,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
201,1463,1,1,,26748060,11057,Active,,,7.0795,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
202,1467,1,3,,26748060,11057,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
203,1468,1,1,,26748060,11057,Active,92096784.0,4137.0,15.8489,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
204,1469,1,1,,17389869,11057,Inconclusive,189491771.0,7068.0,25.1189,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
205,1469,1,1,,26748060,11057,Inconclusive,189491771.0,7068.0,44.6684,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
206,1469,1,1,,26752909,11057,Active,189491771.0,7068.0,100.0,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
207,1471,2,1,,17389869,11057,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
208,1471,2,1,,26748060,11057,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
209,1471,2,1,,26752909,11057,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
210,1476,2,1,,17389869,11057,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
211,1476,2,1,,26748060,11057,Active,281307097.0,,19.9526,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
212,1478,2,1,,17389869,11057,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
213,1478,2,1,,26748060,11057,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
214,1479,1,2,,17389869,11057,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
215,1479,1,2,,26748060,11057,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
216,1479,1,2,,26752909,11057,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
217,1490,2,1,,26748060,11057,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
218,1490,2,1,,26752909,11057,Active,10954339.0,,44.6684,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
219,1519,1,3,,26748060,11057,Inconclusive,,,1.7783,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
220,1576,1,1,,57244299,11057,Inactive,,,,,DSSTox (KIERBL) EPA Estrogen Receptor Ki Binding Study (Laws et al.) Database,Other,,
221,1580,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
222,1581,1,1,,8149358,11057,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
223,1582,1,1,,8149358,11057,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
224,1583,1,1,,8149358,11057,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
225,1584,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
226,1585,1,1,,8149358,11057,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
227,1586,1,1,,8149358,11057,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
228,1587,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
229,1588,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
230,1589,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
231,1590,1,1,,8149358,11057,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
232,1593,1,1,,8149358,11057,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
233,1594,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
234,1595,1,1,,8149358,11057,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
235,1596,1,1,,8149358,11057,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
236,1597,1,1,,8149358,11057,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
237,1598,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
238,1599,1,1,,8149358,11057,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
239,1600,1,1,,8149358,11057,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
240,1601,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
241,1602,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
242,1603,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
243,1604,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
244,1605,1,1,,8149358,11057,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
245,1606,1,1,,8149358,11057,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
246,1607,1,1,,8149358,11057,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
247,1608,1,1,,8149358,11057,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
248,1609,1,1,,8149358,11057,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
249,1610,1,1,,8149358,11057,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
250,1611,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that induce the human heat shock transcriptional response (HSEluc),Other,,
251,1612,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
252,1613,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
253,1614,1,1,,8149358,11057,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
254,1616,1,1,,8149358,11057,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
255,1688,1,1,,26752909,11057,Inconclusive,90903231.0,3064.0,4.4668,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
256,1766,1,1,,26748060,11057,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
257,1766,1,1,,26748060,11057,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
258,1766,1,1,,26752909,11057,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
259,1766,1,1,,26752909,11057,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
260,1768,1,1,,26748060,11057,Inconclusive,18860839.0,4221.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
261,1768,1,1,,26748060,11057,Inconclusive,56550039.0,4297.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
262,1768,1,1,,26752909,11057,Inconclusive,18860839.0,4221.0,7.9433,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
263,1768,1,1,,26752909,11057,Inconclusive,56550039.0,4297.0,7.9433,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
264,1865,1,1,,26748060,11057,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
265,1948,1,1,,17389869,11057,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
266,1948,1,1,,26748060,11057,Inactive,,,3.1623,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
267,2101,1,1,,17389869,11057,Inconclusive,496369.0,2629.0,10.0,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
268,2101,1,1,,26748060,11057,Active,496369.0,2629.0,3.1623,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
269,2107,1,1,,17389869,11057,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
270,2107,1,1,,26748060,11057,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
271,2112,1,1,,17389869,11057,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
272,2112,1,1,,26748060,11057,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
273,2120,1,1,,17389869,11057,Inconclusive,32879895.0,3091.0,15.8489,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
274,2147,1,1,,26748060,11057,Inconclusive,221046486.0,,39.8107,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
275,2451,1,2,,26748060,11057,Active,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
276,2472,1,2,,26748060,11057,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
277,2517,2,1,,17389869,11057,Inconclusive,6980812.0,,19.9526,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
278,2517,2,1,,26748060,11057,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
279,2528,1,2,,26748060,11057,Active,4557365.0,641.0,22.3872,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
280,2528,1,2,,26752909,11057,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
281,2546,1,1,,17389869,11057,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
282,2546,1,1,,26748060,11057,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
283,2546,1,1,,26752909,11057,Active,188536040.0,19885.0,1.5849,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
284,2549,1,1,,17389869,11057,Active,282403581.0,,35.4813,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
285,2549,1,1,,26748060,11057,Active,282403581.0,,10.0,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
286,2551,1,1,,17389869,11057,Active,188536040.0,19885.0,1.122,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
287,2551,1,1,,26748060,11057,Inconclusive,188536040.0,19885.0,22.3872,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
288,2551,1,1,,26752909,11057,Inconclusive,188536040.0,19885.0,6.3096,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
289,2588,1,1,,26748060,11057,Inconclusive,496369.0,2629.0,15.8489,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Activity in Non-Mutant Spleen Homogenate Using a Red Fluorescent Substrate,Confirmatory,,
290,2590,1,1,,26748060,11057,Inconclusive,496369.0,2629.0,11.2202,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Primary Screen Confirmation,Confirmatory,,
291,2596,1,1,,26748060,11057,Inconclusive,496369.0,2629.0,44.6684,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Purified N370S Glucocerebrosidase Cleavage of Glucosylceramide,Confirmatory,,
292,2613,1,1,,26748060,11057,Inconclusive,496369.0,2629.0,31.6228,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Activity in N370S Spleen Homogenate Using a Red Fluorescent Substrate,Confirmatory,,
293,2662,2,1,,26752909,11057,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
294,2671,1,1,,26748060,11057,Inconclusive,496369.0,2629.0,11.2202,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Hit Validation,Confirmatory,,
295,112420,8,1,,103254526,11057,Unspecified,,,536.0,ID50,In vitro inhibitory activity against trypomastigote form of Trypanosoma Cruzi.,Confirmatory,,
296,115267,3,5,,103254526,11057,Unspecified,,,,,"Tested for its ability to eliminate the infective trypomastigote form of Trypanosoma cruzi, Y strain present in blood of infected mice at the dose of 0.12 mM",Other,,
297,208227,8,1,,103254526,11057,Unspecified,,,536.0,ED50,Trypanocidal effect on bloodstream trypomastigotes of Trypanosoma cruzi; ED50/24h,Confirmatory,11985478.0,
298,213792,9,1,,103254526,11057,Unspecified,,,,IC50,Inhibitory concentration against Trypomastigotes (Y strain) of Trypanosoma cruzi,Confirmatory,11591517.0,
299,229349,4,3,,103254526,11057,Unspecified,,,,,Ratio of inhibitory concentration to that of reference drug was determined,Other,11591517.0,
300,265558,3,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi CL Brener trypomastigote form in mouse blood at 250 ug/mL,Other,16722639.0,
301,283558,11,1,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs,Other,17210767.0,
302,283559,11,1,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB after 24 hrs,Other,17210767.0,
303,283560,11,1,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli HNCE4 after 24 hrs,Other,17210767.0,
304,284131,4,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes assessed as parasite lysis at 0.31 mM relative to control,Other,17055730.0,
305,284132,4,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes assessed as parasite lysis at 0.63 mM relative to control,Other,17055730.0,
306,284133,3,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes assessed as parasite lysis at 1.25 mM relative to control,Other,17055730.0,
307,284134,3,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes assessed as parasite lysis at 2.50 mM relative to control,Other,17055730.0,
308,284135,4,3,,103254526,11057,Inconclusive,,,,,Trypanocidal activity against blood stream Trypanosoma cruzi Y trypomastigotes assessed as parasite lysis at 5 mM relative to control,Other,17055730.0,
309,325035,6,4,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Candida albicans SC5314 after 24 hrs by broth macrodilution method,Other,17325226.0,
310,325036,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Candida albicans P5 after 24 hrs by broth macrodilution method,Other,17325226.0,
311,325037,6,4,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Candida albicans SC5314 after 48 hrs by broth macrodilution method,Other,17325226.0,
312,325038,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Candida albicans P5 after 48 hrs by broth macrodilution method,Other,17325226.0,
313,334202,7,1,,103254526,11057,Active,,,,,Trypanocidal activity against Trypanosoma cruzi epimastigotes,Other,12542361.0,
314,334232,6,2,,103254526,11057,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi Y trypomastigotes,Other,11975501.0,
315,336641,3,4,,103254526,11057,Unspecified,,,,,Antiprotozoal activity against trypomastigotes form of Trypanosoma cruzi Y at 250 ug/ml after 24 hrs,Other,7964785.0,
316,338968,7,1,,103254526,11057,Active,,,,,Trypanocidal activity against Trypanosoma cruzi Tulahuen epimastigotes assessed as minimal lethal concentration after 24 hrs,Other,11975490.0,
317,344426,6,2,,103254526,11057,Unspecified,,,536.0,IC50,Antitrypanosomal activity against bloodstream trypomastigote of Trypanosoma cruzi Y assessed as number of motile forms after 24 hrs by hemocytometer,Confirmatory,18570370.0,
318,354545,3,3,,103254526,11057,Active,,,,,Antiparasitic activity against Trypanosoma cruzi Y trypomastigotes assessed as lysis of parasite at 250 ug/mL after 24 hrs,Other,8759169.0,
319,354751,3,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi trypomastigote assessed as lysis of trypomastigotes at 250 ug/mL after 24 hrs relative to control,Other,8699188.0,
320,355818,3,3,,103254526,11057,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes assessed as parasite lysis 7.5 ug/mL after 24 hrs,Other,12762797.0,
321,368418,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
322,368419,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,Other,17548499.0,
323,368420,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
324,368421,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,Other,17548499.0,
325,368422,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,Other,17548499.0,
326,368423,6,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,Other,17548499.0,
327,368424,3,3,,103254526,11057,Unspecified,,,,,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,Other,17548499.0,
328,371470,6,2,,103254526,11057,Unspecified,,,536.0,IC50,Antitrypanosomal activity against Trypanosoma cruzi Y trypomastigotes after 1 day,Confirmatory,18045742.0,
329,373136,3,4,,103254526,11057,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi bloodstream trypomastigote in mouse blood assessed as lysis of trypomastigotes at 250 ug/mL after 24 hrs relative to control,Other,18706738.0,
330,382236,6,2,,103254526,11057,Unspecified,,,536.0,IC50,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes after 24 hrs,Confirmatory,18378461.0,
331,396042,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by broth microdilution method,Other,17638702.0,
332,396280,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by broth microdilution method,Other,17638702.0,
333,396281,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by broth microdilution method,Other,17638702.0,
334,396282,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by broth microdilution method,Other,17638702.0,
335,396283,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by broth microdilution method,Other,17638702.0,
336,396284,6,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by broth microdilution method,Other,17638702.0,
337,399172,3,3,,103254526,11057,Unspecified,,,,,Trypanocidal activity against Trypanosoma cruzi Y strain trypomastigotes infected in Swiss albino mouse blood assessed as reduction of parasitemia at 31 ug/mL after 24 hrs relative to control,Other,9287419.0,
338,399194,6,2,,103254526,11057,Unspecified,,,76.0,IC50,Trypanocidal activity against Trypanosoma cruzi Y trypomastigotes infected in mouse macrophage at 250 ug/ml,Confirmatory,14738383.0,
339,449703,5,2,,103254526,11057,Active,,,0.02213,EC50,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay,Confirmatory,18579783.0,
340,449704,5,2,,103254526,11057,Active,,,0.1703,EC50,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay,Confirmatory,18579783.0,
341,449705,5,2,,103254526,11057,Active,,,1.4340000000000002,CC50,NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7),Confirmatory,18579783.0,
342,449706,5,2,,103254526,11057,Unspecified,,,,,"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.",Other,18579783.0,
343,450067,8,1,,103254526,11057,Active,,,2.1,IC50,Antitrypanosomal activity against Trypanosoma cruzi epimastigote Y strain after 24 hrs by trypan blue exclusion assay,Confirmatory,19683450.0,
344,450069,7,1,,103254526,11057,Unspecified,,,,,Cytotoxicity against BALB/c mouse splenocyte assessed as [3H]thymidine incorporation by beta-counting,Other,19683450.0,
345,485281,1,1,,26748060,11057,Inconclusive,254220970.0,,50.1187,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
346,485290,1,1,,17389869,11057,Inactive,20150581.0,,4.4668,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
347,485290,1,1,,26748060,11057,Inactive,20150581.0,,1.2589,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
348,485290,1,1,,26752909,11057,Inactive,20150581.0,,1.7783,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
349,485350,1,2,,92123955,11057,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
350,492961,1,1,,26752909,11057,Inconclusive,72386991.0,3656265.0,14.1254,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
351,492967,1,2,,99301119,11057,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
352,493033,1,2,,92123955,11057,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
353,493162,1,2,,99301119,11057,Active,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
354,498877,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli RAM4100 by agar dilution method,Other,19884363.0,
355,498878,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia coli RAM1129 by agar dilution method,Other,19884363.0,
356,498879,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia cloi RAM1129 transfected with pGCC4 containg IPTG-inducible lacZ promoter by agar dilution method,Other,19884363.0,
357,498880,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Escherichia cloi RAM1129 transfected with pNK1 containg Neisseria meningitidis tolC gene by agar dilution method,Other,19884363.0,
358,504327,1,1,,26748060,11057,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
359,504327,1,1,,26752909,11057,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
360,504332,1,1,,26748060,11057,Inconclusive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
361,504332,1,1,,26752909,11057,Inconclusive,168985070.0,,0.3981,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
362,504749,1,3,,26752909,11057,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
363,504749,1,3,1.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
364,504749,1,3,2.0,26752909,11057,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
365,504749,1,3,3.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
366,504749,1,3,4.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
367,504749,1,3,5.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
368,504749,1,3,6.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
369,504749,1,3,7.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
370,504749,1,3,8.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
371,504749,1,3,9.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
372,504749,1,3,10.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
373,504749,1,3,11.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
374,504749,1,3,12.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
375,504749,1,3,13.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
376,504749,1,3,14.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
377,504749,1,3,15.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
378,504749,1,3,16.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
379,504749,1,3,17.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
380,504749,1,3,18.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
381,504749,1,3,19.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
382,504749,1,3,20.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
383,504749,1,3,21.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
384,504749,1,3,22.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
385,504749,1,3,23.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
386,504749,1,3,24.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
387,504749,1,3,25.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
388,504749,1,3,26.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
389,504749,1,3,27.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
390,504749,1,3,28.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
391,504749,1,3,29.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
392,504749,1,3,30.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
393,504749,1,3,31.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
394,504749,1,3,32.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
395,504749,1,3,33.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
396,504749,1,3,34.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
397,504749,1,3,35.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
398,504749,1,3,36.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
399,504749,1,3,37.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
400,504749,1,3,38.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
401,504749,1,3,39.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
402,504749,1,3,40.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
403,504749,1,3,41.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
404,504749,1,3,42.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
405,504749,1,3,43.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
406,504749,1,3,44.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
407,504749,1,3,45.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
408,504749,1,3,46.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
409,504749,1,3,47.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
410,504749,1,3,48.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
411,504749,1,3,49.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
412,504749,1,3,50.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
413,504749,1,3,51.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
414,504749,1,3,52.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
415,504749,1,3,53.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
416,504749,1,3,54.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
417,504749,1,3,55.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
418,504749,1,3,56.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
419,504749,1,3,57.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
420,504749,1,3,58.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
421,504749,1,3,59.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
422,504749,1,3,60.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
423,504749,1,3,61.0,26752909,11057,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
424,504770,1,2,,92123955,11057,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
425,504832,1,1,,26752909,11057,Active,,,0.3013,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
426,504834,1,1,,26752909,11057,Active,,,0.1901,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
427,504847,1,1,,26748060,11057,Active,63054845.0,7421.0,31.6228,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
428,504847,1,1,,26752909,11057,Active,63054845.0,7421.0,39.8107,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
429,504865,1,1,,26748060,11057,Active,118600387.0,7398.0,19.9526,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
430,504865,1,1,,26752909,11057,Active,118600387.0,7398.0,22.3872,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
431,510559,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB,Other,20038628.0,
432,510747,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pSport1-based acrB gene,Other,20038628.0,
433,510748,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring naive acrB gene,Other,20038628.0,
434,510749,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pP10-based acrB gene,Other,20038628.0,
435,510750,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pS1328-based acrB gene,Other,20038628.0,
436,532573,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method,Other,18694955.0,
437,532580,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method,Other,18694955.0,
438,532762,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine,Other,18694955.0,
439,532763,2,4,,103254526,11057,Inconclusive,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine,Other,18694955.0,
440,532764,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method,Other,18694955.0,
441,532765,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG,Other,18694955.0,
442,532766,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine,Other,18694955.0,
443,534106,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method,Other,18725450.0,
444,534107,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
445,534108,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
446,534109,1,3,,103254526,11057,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm0527,Other,18725450.0,
447,534110,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
448,534111,5,2,,103254526,11057,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
449,534112,1,3,,103254526,11057,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm1980,Other,18725450.0,
450,540299,1,2,,92123955,11057,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
451,572147,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
452,572150,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
453,572151,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
454,576014,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,Other,20660673.0,
455,576015,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,Other,20660673.0,
456,576016,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,Other,20660673.0,
457,576017,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,Other,20660673.0,
458,576018,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,Other,20660673.0,
459,576019,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,Other,20660673.0,
460,576020,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,Other,20660673.0,
461,576021,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,Other,20660673.0,
462,576022,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,Other,20660673.0,
463,576023,5,2,,103254526,11057,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,Other,20660673.0,
464,588211,2,3,,103254526,11057,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
465,588212,2,3,,103254526,11057,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
466,588213,2,3,,103254526,11057,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
467,588513,1,1,,17389869,11057,Active,348019627.0,2099.0,28.1838,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
468,588513,1,1,,26752909,11057,Inconclusive,348019627.0,2099.0,2.5119,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
469,588514,1,1,,17389869,11057,Inconclusive,348019627.0,2099.0,15.8489,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
470,588514,1,1,,26752909,11057,Inconclusive,348019627.0,2099.0,2.5119,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
471,588515,1,1,,17389869,11057,Inconclusive,124375976.0,367.0,3.5481,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
472,588515,1,1,,26752909,11057,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
473,588516,1,1,,17389869,11057,Inconclusive,124375976.0,367.0,8.9125,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
474,588516,1,1,,26752909,11057,Inconclusive,124375976.0,367.0,10.0,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
475,588519,1,2,,92123955,11057,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
476,588526,1,1,,17389869,11057,Inconclusive,325495553.0,9971.0,50.1187,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
477,588526,1,1,,26752909,11057,Inconclusive,325495553.0,9971.0,50.1187,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
478,588527,1,1,,17389869,11057,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
479,588527,1,1,,26752909,11057,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
480,588532,1,1,,17389869,11057,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
481,588532,1,1,,26752909,11057,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
482,588533,1,1,,17389869,11057,Inconclusive,311348376.0,2908.0,28.1838,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
483,588533,1,1,,26752909,11057,Inconclusive,311348376.0,2908.0,44.6684,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
484,588534,1,1,,17389869,11057,Inconclusive,216409690.0,5467.0,25.1189,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
485,588534,1,1,,26752909,11057,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
486,588535,1,1,,17389869,11057,Inconclusive,216409690.0,5467.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
487,588535,1,1,,26752909,11057,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
488,588536,1,1,,17389869,11057,Inconclusive,216409692.0,5468.0,39.8107,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
489,588536,1,1,,26752909,11057,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
490,588537,1,1,,17389869,11057,Inconclusive,216409692.0,5468.0,39.8107,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
491,588537,1,1,,26752909,11057,Active,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
492,588541,1,1,,17389869,11057,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
493,588541,1,1,,26752909,11057,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
494,588543,1,1,,17389869,11057,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
495,588543,1,1,,26752909,11057,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
496,588544,1,1,,17389869,11057,Inconclusive,325495497.0,6256.0,12.5893,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
497,588544,1,1,,26752909,11057,Inconclusive,325495497.0,6256.0,3.5481,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
498,588545,1,1,,17389869,11057,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
499,588545,1,1,,26752909,11057,Inconclusive,189491771.0,7068.0,28.1838,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
500,588546,1,1,,17389869,11057,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
501,588546,1,1,,26752909,11057,Inconclusive,325495497.0,6256.0,7.9433,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
502,588547,1,1,,17389869,11057,Active,189491771.0,7068.0,28.1838,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
503,588547,1,1,,26752909,11057,Inconclusive,189491771.0,7068.0,25.1189,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
504,588579,1,1,,26748060,11057,Inconclusive,7705344.0,51426.0,15.8489,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
505,588579,1,1,,26752909,11057,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
506,588812,1,1,,17389869,11057,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
507,588812,1,1,1.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
508,588812,1,1,2.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
509,588812,1,1,3.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
510,588812,1,1,4.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
511,588812,1,1,5.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
512,588812,1,1,6.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
513,588812,1,1,7.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
514,588812,1,1,8.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
515,588812,1,1,9.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
516,588812,1,1,10.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
517,588812,1,1,11.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
518,588812,1,1,12.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
519,588812,1,1,13.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
520,588812,1,1,14.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
521,588812,1,1,15.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
522,588812,1,1,16.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
523,588812,1,1,17.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
524,588812,1,1,18.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
525,588812,1,1,19.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
526,588812,1,1,20.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
527,588812,1,1,21.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
528,588812,1,1,22.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
529,588812,1,1,23.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
530,588812,1,1,24.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
531,588812,1,1,25.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
532,588812,1,1,26.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
533,588812,1,1,27.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
534,588812,1,1,28.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
535,588812,1,1,29.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
536,588812,1,1,30.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
537,588812,1,1,31.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
538,588812,1,1,32.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
539,588812,1,1,33.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
540,588812,1,1,34.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
541,588812,1,1,35.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
542,588812,1,1,36.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
543,588812,1,1,37.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
544,588812,1,1,38.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
545,588812,1,1,39.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
546,588812,1,1,40.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
547,588812,1,1,41.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
548,588812,1,1,42.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
549,588812,1,1,43.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
550,588812,1,1,44.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
551,588812,1,1,45.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
552,588812,1,1,46.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
553,588812,1,1,47.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
554,588812,1,1,48.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
555,588812,1,1,49.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
556,588812,1,1,50.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
557,588812,1,1,51.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
558,588812,1,1,52.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
559,588812,1,1,53.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
560,588812,1,1,54.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
561,588812,1,1,55.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
562,588812,1,1,56.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
563,588812,1,1,57.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
564,588812,1,1,58.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
565,588812,1,1,59.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
566,588812,1,1,60.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
567,588812,1,1,61.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
568,588812,1,1,62.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
569,588812,1,1,63.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
570,588812,1,1,64.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
571,588812,1,1,65.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
572,588812,1,1,66.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
573,588812,1,1,67.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
574,588812,1,1,68.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
575,588812,1,1,69.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
576,588812,1,1,70.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
577,588812,1,1,71.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
578,588812,1,1,72.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
579,588812,1,1,73.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
580,588812,1,1,74.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
581,588812,1,1,75.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
582,588812,1,1,76.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
583,588812,1,1,77.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
584,588812,1,1,78.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
585,588812,1,1,79.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
586,588812,1,1,80.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
587,588812,1,1,81.0,17389869,11057,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
588,588813,1,1,,17389869,11057,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
589,588813,1,1,1.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
590,588813,1,1,2.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
591,588813,1,1,3.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
592,588813,1,1,4.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
593,588813,1,1,5.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
594,588813,1,1,6.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
595,588813,1,1,7.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
596,588813,1,1,8.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
597,588813,1,1,9.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
598,588813,1,1,10.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
599,588813,1,1,11.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
600,588813,1,1,12.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
601,588813,1,1,13.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
602,588813,1,1,14.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
603,588813,1,1,15.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
604,588813,1,1,16.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
605,588813,1,1,17.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
606,588813,1,1,18.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
607,588813,1,1,19.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
608,588813,1,1,20.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
609,588813,1,1,21.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
610,588813,1,1,22.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
611,588813,1,1,23.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
612,588813,1,1,24.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
613,588813,1,1,25.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
614,588813,1,1,26.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
615,588813,1,1,27.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
616,588813,1,1,28.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
617,588813,1,1,29.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
618,588813,1,1,30.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
619,588813,1,1,31.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
620,588813,1,1,32.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
621,588813,1,1,33.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
622,588813,1,1,34.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
623,588813,1,1,35.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
624,588813,1,1,36.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
625,588813,1,1,37.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
626,588813,1,1,38.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
627,588813,1,1,39.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
628,588813,1,1,40.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
629,588813,1,1,41.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
630,588813,1,1,42.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
631,588813,1,1,43.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
632,588813,1,1,44.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
633,588813,1,1,45.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
634,588813,1,1,46.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
635,588813,1,1,47.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
636,588813,1,1,48.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
637,588813,1,1,49.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
638,588813,1,1,50.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
639,588813,1,1,51.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
640,588813,1,1,52.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
641,588813,1,1,53.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
642,588813,1,1,54.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
643,588813,1,1,55.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
644,588813,1,1,56.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
645,588813,1,1,57.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
646,588813,1,1,58.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
647,588813,1,1,59.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
648,588813,1,1,60.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
649,588813,1,1,61.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
650,588813,1,1,62.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
651,588813,1,1,63.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
652,588813,1,1,64.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
653,588813,1,1,65.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
654,588813,1,1,66.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
655,588813,1,1,67.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
656,588813,1,1,68.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
657,588813,1,1,69.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
658,588813,1,1,70.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
659,588813,1,1,71.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
660,588813,1,1,72.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
661,588813,1,1,73.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
662,588813,1,1,74.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
663,588813,1,1,75.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
664,588813,1,1,76.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
665,588813,1,1,77.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
666,588813,1,1,78.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
667,588813,1,1,79.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
668,588813,1,1,80.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
669,588813,1,1,81.0,17389869,11057,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
670,588834,2,1,,17389869,11057,Active,325651834.0,3757.0,12.5893,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
671,588834,2,1,,144204635,11057,Active,325651834.0,3757.0,10.0,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
672,597221,1,6,,103254526,11057,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi CL Brener clone trypomastigotes in parasite infected BALB/c mouse blood assessed as parasite lysis at 250 ug/ml after 24 hrs relative to control,Other,21506600.0,
673,602314,1,2,,92123955,11057,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
674,602332,1,1,,26748060,11057,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
675,602332,1,1,,26752909,11057,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
676,614076,1,3,,103254526,11057,Active,,,,,Displacement of Thioflavin T from synthetic Tau 2N4R aggregate by fluorescence assay at 1 uM probe concentration,Other,21803586.0,
677,614077,1,3,,103254526,11057,Active,,,,,Displacement of Thioflavin S from synthetic Tau 2N4R aggregate by fluorescence assay at 10 uM probe concentration,Other,21803586.0,
678,624030,1,2,,26752909,11057,Active,160794.0,,12.8178,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
679,624031,1,2,,26752909,11057,Active,,,9.0743,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
680,624032,1,2,,26752909,11057,Active,8393992.0,24660.0,9.0743,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
681,624044,1,2,,26752909,11057,Inconclusive,8393992.0,24660.0,8.9058,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
682,624170,1,1,,26752909,11057,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
683,624172,1,1,,26752909,11057,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
684,624173,1,3,,26752909,11057,Inconclusive,62359610.0,,19.9526,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
685,624296,1,1,,26752909,11057,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
686,624297,1,1,,26752909,11057,Inconclusive,7705682.0,51053.0,5.3091,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
687,624349,1,2,,92123955,11057,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
688,624349,1,2,,92307345,11057,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
689,625144,5,5,,103254526,11057,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
690,625145,4,7,,103254526,11057,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
691,625146,5,5,,103254526,11057,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
692,625147,4,7,,103254526,11057,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
693,625148,4,7,,103254526,11057,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
694,625149,4,7,,103254526,11057,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
695,625150,5,5,,103254526,11057,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
696,625151,4,7,,103254526,11057,Active,113118.0,1128.0,1.095,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
697,625152,4,7,,103254526,11057,Active,113122.0,1129.0,1.43,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
698,625153,4,7,,103254526,11057,Active,113125.0,1131.0,4.33,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
699,625154,4,7,,103254526,11057,Active,23503039.0,1132.0,1.005,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
700,625155,4,7,,103254526,11057,Active,543761.0,1133.0,0.535,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
701,625156,1,9,,103254526,11057,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
702,625157,6,2,,103254526,11057,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
703,625158,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
704,625159,5,5,,103254526,11057,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
705,625160,1,9,,103254526,11057,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
706,625161,4,7,,103254526,11057,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
707,625162,4,7,,103254526,11057,Active,116242691.0,4986.0,1.54,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
708,625163,4,7,,103254526,11057,Active,2851402.0,4988.0,2.145,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
709,625164,1,6,,103254526,11057,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
710,625165,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
711,625166,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
712,625167,5,5,,103254526,11057,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
713,625168,4,7,,103254526,11057,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
714,625169,1,6,,103254526,11057,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
715,625170,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
716,625171,4,7,,103254526,11057,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
717,625172,4,7,,103254526,11057,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
718,625173,5,5,,103254526,11057,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
719,625174,5,5,,103254526,11057,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
720,625175,5,5,,103254526,11057,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
721,625176,1,9,,103254526,11057,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
722,625177,5,5,,103254526,11057,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
723,625178,5,5,,103254526,11057,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
724,625179,1,9,,103254526,11057,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
725,625180,5,5,,103254526,11057,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
726,625181,5,5,,103254526,11057,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
727,625182,5,5,,103254526,11057,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
728,625183,5,5,,103254526,11057,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
729,625184,5,5,,103254526,11057,Active,2811086.0,1956.0,0.473,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
730,625185,5,5,,103254526,11057,Active,125370.0,2534.0,2.148,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
731,625186,5,5,,103254526,11057,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
732,625187,5,5,,103254526,11057,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
733,625188,1,9,,103254526,11057,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
734,625189,1,7,,103254526,11057,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
735,625190,4,5,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
736,625191,4,7,,103254526,11057,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
737,625192,4,7,,103254526,11057,Active,543727.0,3356.0,2.627,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
738,625193,5,5,,103254526,11057,Active,113037.0,43.0,5.847,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
739,625194,4,7,,103254526,11057,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
740,625195,4,7,,103254526,11057,Active,543740.0,135.0,3.365,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
741,625196,5,6,,103254526,11057,Active,803374855.0,140.0,4.166,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
742,625197,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
743,625198,4,7,,103254526,11057,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
744,625199,4,7,,103254526,11057,Active,543734.0,24173.0,3.595,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
745,625200,4,7,,103254526,11057,Active,1168243.0,146.0,1.98,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
746,625201,4,7,,103254526,11057,Active,1351829.0,150.0,0.536,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
747,625202,4,7,,103254526,11057,Active,613504690.0,151.0,1.258,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
748,625203,4,7,,103254526,11057,Active,20141211.0,152.0,1.8840000000000001,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
749,625204,4,7,,103254526,11057,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
750,625205,4,7,,103254526,11057,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
751,625206,4,7,,103254526,11057,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
752,625207,4,7,,103254526,11057,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
753,625208,5,5,,103254526,11057,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
754,625209,4,7,,103254526,11057,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
755,625210,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
756,625211,1,6,,103254526,11057,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
757,625212,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
758,625213,4,7,,103254526,11057,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
759,625214,1,9,,103254526,11057,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
760,625215,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
761,625216,3,4,,103254526,11057,Active,,,2.133,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
762,625217,4,7,,103254526,11057,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
763,625218,4,7,,103254526,11057,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
764,625219,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
765,625220,4,7,,103254526,11057,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
766,625221,4,7,,103254526,11057,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
767,625222,4,7,,103254526,11057,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
768,625223,4,7,,103254526,11057,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
769,625224,3,4,,103254526,11057,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
770,625225,3,4,,103254526,11057,Active,,,0.46,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
771,625226,4,7,,103254526,11057,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
772,625227,4,7,,103254526,11057,Active,229462950.0,6865.0,1.679,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
773,625228,4,7,,103254526,11057,Active,113832.0,24208.0,5.57,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
774,625229,5,5,,103254526,11057,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
775,625230,1,6,,103254526,11057,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
776,625231,4,7,,103254526,11057,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
777,625232,1,9,,103254526,11057,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
778,625233,4,7,,103254526,11057,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
779,625234,3,4,,103254526,11057,Active,,,3.4410000000000003,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
780,625235,4,7,,103254526,11057,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
781,625236,5,5,,103254526,11057,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
782,625237,4,7,,103254526,11057,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
783,625238,4,7,,103254526,11057,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
784,625239,4,7,,103254526,11057,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
785,625240,1,9,,103254526,11057,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
786,625241,4,7,,103254526,11057,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
787,625242,4,7,,103254526,11057,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
788,625243,5,5,,103254526,11057,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
789,625244,5,5,,103254526,11057,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
790,625245,5,5,,103254526,11057,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
791,625246,1,9,,103254526,11057,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
792,625247,5,5,,103254526,11057,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
793,625248,5,5,,103254526,11057,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
794,625249,5,5,,103254526,11057,Active,84028191.0,1565.0,0.8244,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
795,625250,5,5,,103254526,11057,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
796,625251,5,5,,103254526,11057,Active,116241312.0,1576.0,3.6337,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
797,625252,4,7,,103254526,11057,Active,118228.0,1812.0,3.102,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
798,625253,4,7,,103254526,11057,Active,118206.0,1813.0,3.178,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
799,625254,4,7,,103254526,11057,Active,1169206.0,1814.0,0.831,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
800,625255,4,7,,103254526,11057,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
801,625256,4,7,,103254526,11057,Active,266667.0,6531.0,4.069,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
802,625257,4,7,,103254526,11057,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
803,625258,4,7,,103254526,11057,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
804,625259,4,7,,103254526,11057,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
805,625260,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
806,625261,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
807,625262,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
808,625263,4,7,,103254526,11057,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
809,625264,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
810,625265,1,6,,103254526,11057,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
811,625266,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
812,625267,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
813,625268,4,2,,103254526,11057,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
814,625268,4,2,,103254526,11057,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
815,625268,4,2,,103254526,11057,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
816,625268,4,2,,103254526,11057,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
817,625269,4,7,,103254526,11057,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
818,625270,4,7,,103254526,11057,Active,123120.0,3274.0,1.155,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
819,625271,5,5,,103254526,11057,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
820,625272,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
821,625273,4,6,,103254526,11057,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
822,625274,1,6,,103254526,11057,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
823,625275,3,4,,103254526,11057,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
824,651631,4,1,,144204635,11057,Inconclusive,269849759.0,7157.0,23.7101,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
825,651631,4,1,,144208960,11057,Inconclusive,269849759.0,7157.0,12.1352,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
826,651631,4,1,,144210888,11057,Inconclusive,269849759.0,7157.0,27.305999999999997,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
827,651632,4,1,,144204635,11057,Inactive,296439460.0,79915.0,0.5956,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
828,651632,4,1,,144208960,11057,Inconclusive,296439460.0,79915.0,27.1672,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
829,651632,4,1,,144210888,11057,Inactive,296439460.0,79915.0,0.3857,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
830,651633,4,1,,144204635,11057,Active,,,10.5909,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
831,651633,4,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
832,651633,4,1,,144210888,11057,Active,,,30.6379,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
833,651634,4,1,,144204635,11057,Active,,,11.8832,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
834,651634,4,1,,144208960,11057,Active,,,21.5797,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
835,651634,4,1,,144210888,11057,Active,,,24.3365,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
836,651741,1,1,,17389869,11057,Inconclusive,20149576.0,4780.0,33.4915,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
837,651741,1,1,,144204635,11057,Inconclusive,20149576.0,4780.0,34.3762,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
838,651743,1,1,,17389869,11057,Inconclusive,269849759.0,7157.0,44.6684,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
839,651743,1,1,,144204635,11057,Inconclusive,269849759.0,7157.0,44.6684,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
840,651749,1,1,,17389869,11057,Inconclusive,34577122.0,4790.0,31.6228,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
841,651749,1,1,,144204635,11057,Inconclusive,34577122.0,4790.0,39.8107,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
842,651751,1,1,,17389869,11057,Inactive,5702233.0,84385.0,39.8107,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
843,651751,1,1,,144204635,11057,Inactive,5702233.0,84385.0,5.0119,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
844,651754,1,1,,17389869,11057,Active,,,0.6682,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
845,651755,1,1,,17389869,11057,Active,,,1.1883,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
846,651757,1,1,,17389869,11057,Inconclusive,25952111.0,7124.0,42.1632,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
847,651758,1,1,,17389869,11057,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
848,651777,1,1,,17389869,11057,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
849,651777,1,1,,144204635,11057,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
850,651778,1,1,,17389869,11057,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
851,651778,1,1,,144204635,11057,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
852,651802,1,1,,17389869,11057,Active,49066040.0,6097.0,2.371,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
853,651838,1,1,,17389869,11057,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
854,651838,1,1,,144204635,11057,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
855,651838,1,1,1.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
856,651838,1,1,1.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
857,651838,1,1,2.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
858,651838,1,1,2.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
859,651838,1,1,3.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
860,651838,1,1,3.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
861,651838,1,1,4.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
862,651838,1,1,4.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
863,651838,1,1,5.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
864,651838,1,1,5.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
865,651838,1,1,6.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
866,651838,1,1,6.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
867,651838,1,1,7.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
868,651838,1,1,7.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
869,651838,1,1,8.0,17389869,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
870,651838,1,1,8.0,144204635,11057,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
871,652048,1,2,,144204635,11057,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
872,652051,1,1,,144204635,11057,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
873,660266,2,2,,103254526,11057,Unspecified,,,536.0,IC50,Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis,Confirmatory,22483633.0,
874,681117,3,6,,103254526,11057,Unspecified,313104181.0,6580.0,,IC50,TP_TRANSPORTER: inhibition of TEA uptake in OCT1-expressing HeLa cells,Confirmatory,12606755.0,
875,686978,1,1,,26748060,11057,Active,79154014.0,55775.0,0.5174,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
876,686978,1,1,,144204635,11057,Active,79154014.0,55775.0,0.2661,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
877,686979,1,1,,26748060,11057,Active,79154014.0,55775.0,0.2311,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
878,686979,1,1,,144204635,11057,Active,79154014.0,55775.0,0.2661,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
879,694951,2,2,,103254526,11057,Unspecified,,,,,Cytotoxicity against BALB/c mouse splenocytes after 24 hrs by [3H]-thymidine incorporation assay,Other,23006639.0,
880,720516,2,1,,144204635,11057,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
881,720516,2,1,,144208960,11057,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
882,720516,2,1,,144210888,11057,Inconclusive,296439460.0,79915.0,0.566142,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
883,720532,1,1,,26748060,11057,Active,420597.0,,1.4125,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
884,720532,1,1,,144204635,11057,Active,420597.0,,2.8184,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
885,720533,1,1,,26748060,11057,Active,,,1.7783,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
886,720533,1,1,,144204635,11057,Active,,,0.631,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
887,720552,2,1,,144204635,11057,Inconclusive,269849759.0,7157.0,20.3361,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
888,720552,2,1,,144208960,11057,Inconclusive,269849759.0,7157.0,53.1756,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
889,720552,2,1,,144210888,11057,Inconclusive,269849759.0,7157.0,61.1306,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
890,720579,2,1,,26748060,11057,Inactive,222762.0,3707576.0,12.5893,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
891,720580,1,1,,26748060,11057,Active,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
892,720634,2,1,,144204635,11057,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
893,720634,2,1,,144208960,11057,Active,,,54.2058,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
894,720634,2,1,,144210888,11057,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
895,720635,2,1,,144204635,11057,Active,,,0.1394,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
896,720635,2,1,,144208960,11057,Active,,,0.0305,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
897,720635,2,1,,144210888,11057,Active,,,0.0686,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
898,720636,1,1,,17389869,11057,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
899,720636,1,1,,144204635,11057,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
900,720637,2,1,,144204635,11057,Active,,,0.17036800000000002,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
901,720637,2,1,,144208960,11057,Active,,,0.0552559,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
902,720637,2,1,,144210888,11057,Active,,,0.07406139999999999,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
903,720641,1,2,,92307345,11057,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
904,720652,1,1,,17389869,11057,Active,,,10.5909,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
905,720653,1,1,,17389869,11057,Active,,,12.5893,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
906,720653,1,1,,144204635,11057,Active,,,25.1189,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
907,720659,1,1,,17389869,11057,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
908,720659,1,1,,144204635,11057,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
909,720674,2,2,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
910,720674,2,2,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
911,720674,2,2,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
912,720675,2,2,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
913,720675,2,2,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
914,720675,2,2,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
915,720678,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
916,720678,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
917,720678,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
918,720679,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
919,720679,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
920,720679,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
921,720680,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
922,720680,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
923,720680,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
924,720681,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
925,720681,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
926,720681,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
927,720682,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
928,720682,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
929,720682,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
930,720683,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
931,720683,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
932,720683,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
933,720684,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
934,720684,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
935,720684,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
936,720685,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
937,720685,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
938,720685,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
939,720686,2,1,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
940,720686,2,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
941,720686,2,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
942,720687,2,2,,144204635,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
943,720687,2,2,,144208960,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
944,720687,2,2,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
945,720691,4,1,,144204635,11057,Inactive,311348376.0,2908.0,11.9856,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
946,720691,4,1,,144208960,11057,Inconclusive,311348376.0,2908.0,12.2411,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
947,720691,4,1,,144210888,11057,Inconclusive,311348376.0,2908.0,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
948,720692,3,1,,144204635,11057,Inconclusive,311348376.0,2908.0,16.9301,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
949,720692,3,1,,144208960,11057,Inconclusive,311348376.0,2908.0,15.4106,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
950,720692,3,1,,144210888,11057,Inconclusive,311348376.0,2908.0,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
951,720693,3,1,,144204635,11057,Active,,,6.007000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
952,720693,3,1,,144208960,11057,Active,,,3.45,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
953,720693,3,1,,144210888,11057,Active,,,9.77,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
954,720717,1,3,,92123955,11057,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
955,720717,1,3,,92307345,11057,Active,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
956,720719,2,1,,144204635,11057,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
957,720719,2,1,,144208960,11057,Inconclusive,311348376.0,2908.0,37.2523,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
958,720719,2,1,,144210888,11057,Inconclusive,311348376.0,2908.0,48.9662,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
959,720725,2,1,,144204635,11057,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
960,720725,2,1,,144208960,11057,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
961,720725,2,1,,144210888,11057,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
962,723185,1,2,,103254526,11057,Active,,,31.0,IC50,Antitrypanosomal activity against Trypanosoma cruzi Y bloodstream trypomastigotes isolated from infected Swiss mouse blood assessed as lysis level after 24 hrs,Confirmatory,23279867.0,
963,743012,3,1,,144204635,11057,Active,,,0.3349,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
964,743012,3,1,,144208960,11057,Active,,,0.5421,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
965,743012,3,1,,144210888,11057,Active,,,0.1933,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
966,743014,3,1,,144204635,11057,Active,,,0.4731,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
967,743014,3,1,,144208960,11057,Active,,,0.4831,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
968,743014,3,1,,144210888,11057,Active,,,0.2434,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
969,743015,3,1,,144204635,11057,Active,,,0.4216,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
970,743015,3,1,,144208960,11057,Active,,,0.4831,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
971,743015,3,1,,144210888,11057,Active,,,0.1933,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
972,743033,3,1,,144204635,11057,Active,,,1.693,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
973,743033,3,1,,144208960,11057,Active,,,1.3735,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
974,743033,3,1,,144210888,11057,Active,,,0.3467,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
975,743035,2,1,,144204635,11057,Inconclusive,124375976.0,367.0,1.3448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
976,743035,2,1,,144208960,11057,Inconclusive,124375976.0,367.0,0.7724,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
977,743035,2,1,,144210888,11057,Active,124375976.0,367.0,0.3467,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
978,743036,2,1,,144204635,11057,Inconclusive,124375976.0,367.0,0.0952,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
979,743036,2,1,,144208960,11057,Inconclusive,124375976.0,367.0,43.433,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
980,743036,2,1,,144210888,11057,Inconclusive,124375976.0,367.0,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
981,743040,3,1,,144204635,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
982,743040,3,1,,144208960,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
983,743040,3,1,,144210888,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
984,743041,3,1,,144204635,11057,Active,,,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
985,743041,3,1,,144208960,11057,Active,,,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
986,743041,3,1,,144210888,11057,Active,,,4.3277,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
987,743042,3,1,,144204635,11057,Active,124375976.0,367.0,2.371,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
988,743042,3,1,,144208960,11057,Active,124375976.0,367.0,0.8591,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
989,743042,3,1,,144210888,11057,Active,124375976.0,367.0,0.8635,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
990,743053,2,1,,144204635,11057,Inconclusive,124375976.0,367.0,23.9145,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
991,743053,2,1,,144208960,11057,Active,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
992,743053,2,1,,144210888,11057,Active,124375976.0,367.0,29.1673,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
993,743054,2,1,,144204635,11057,Inconclusive,124375976.0,367.0,2.4637700000000002,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
994,743054,2,1,,144208960,11057,Active,124375976.0,367.0,1.47021,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
995,743054,2,1,,144210888,11057,Active,124375976.0,367.0,1.2674299999999998,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
996,743063,2,1,,144204635,11057,Inconclusive,124375976.0,367.0,1.2941799999999999,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
997,743063,2,1,,144208960,11057,Active,124375976.0,367.0,0.29028200000000004,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
998,743063,2,1,,144210888,11057,Inconclusive,124375976.0,367.0,0.374309,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
999,743064,3,1,,144204635,11057,Active,,,1.8834,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1000,743064,3,1,,144208960,11057,Active,,,0.8591,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1001,743064,3,1,,144210888,11057,Active,,,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1002,743065,3,1,,144204635,11057,Active,399498506.0,24831.0,1.3333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1003,743065,3,1,,144208960,11057,Active,399498506.0,24831.0,0.4306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1004,743065,3,1,,144210888,11057,Active,399498506.0,24831.0,0.5448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1005,743066,3,1,,144204635,11057,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1006,743066,3,1,,144208960,11057,Inconclusive,399498506.0,24831.0,1.0815,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1007,743066,3,1,,144210888,11057,Inconclusive,399498506.0,24831.0,0.8635,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1008,743067,2,1,,144204635,11057,Inconclusive,399498506.0,24831.0,1.33332,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1009,743067,2,1,,144208960,11057,Inconclusive,399498506.0,24831.0,0.447417,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1010,743067,2,1,,144210888,11057,Inconclusive,399498506.0,24831.0,0.467296,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1011,743069,2,1,,144204635,11057,Inconclusive,348019627.0,2099.0,0.8485,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1012,743069,2,1,,144208960,11057,Inconclusive,348019627.0,2099.0,0.3075,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1013,743069,2,1,,144210888,11057,Active,348019627.0,2099.0,34.6654,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1014,743074,2,1,,144204635,11057,Active,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1015,743074,2,1,,144208960,11057,Active,,,8.666,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1016,743074,2,1,,144210888,11057,Active,,,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1017,743075,2,1,,144204635,11057,Inconclusive,348019627.0,2099.0,16.9301,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1018,743075,2,1,,144208960,11057,Active,348019627.0,2099.0,3.0748,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1019,743075,2,1,,144210888,11057,Inconclusive,348019627.0,2099.0,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1020,743077,2,1,,144204635,11057,Inconclusive,348019627.0,2099.0,17.5753,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1021,743077,2,1,,144208960,11057,Active,348019627.0,2099.0,6.884519999999999,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1022,743077,2,1,,144210888,11057,Inconclusive,348019627.0,2099.0,43.6519,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1023,743078,2,1,,144204635,11057,Inconclusive,348019627.0,2099.0,10.0846,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1024,743078,2,1,,144208960,11057,Inconclusive,348019627.0,2099.0,9.72344,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1025,743078,2,1,,144210888,11057,Active,348019627.0,2099.0,0.297324,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1026,743079,3,1,,144204635,11057,Inconclusive,348019627.0,2099.0,3.7578,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1027,743079,3,1,,144208960,11057,Inconclusive,348019627.0,2099.0,2.4213,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1028,743079,3,1,,144210888,11057,Inconclusive,348019627.0,2099.0,4.8558,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1029,743080,3,1,,144204635,11057,Inconclusive,348019627.0,2099.0,5.9557,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1030,743080,3,1,,144208960,11057,Active,348019627.0,2099.0,2.4213,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1031,743080,3,1,,144210888,11057,Active,348019627.0,2099.0,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1032,743081,3,1,,144204635,11057,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1033,743081,3,1,,144208960,11057,Active,,,12.1352,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1034,743081,3,1,,144210888,11057,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1035,743083,3,1,,144204635,11057,Active,119597822.0,1588.0,2.9849,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1036,743083,3,1,,144208960,11057,Active,119597822.0,1588.0,0.6082,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1037,743083,3,1,,144210888,11057,Active,119597822.0,1588.0,0.8635,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1038,743084,3,1,,144204635,11057,Active,,,10.5909,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1039,743084,3,1,,144208960,11057,Active,,,3.0482,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1040,743084,3,1,,144210888,11057,Active,,,7.6959,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1041,743085,3,1,,144204635,11057,Inconclusive,51095037.0,196.0,2.371,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1042,743085,3,1,,144208960,11057,Active,51095037.0,196.0,2.4213,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1043,743085,3,1,,144210888,11057,Inconclusive,51095037.0,196.0,2.7306,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1044,743086,3,1,,144204635,11057,Active,,,9.4392,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1045,743086,3,1,,144208960,11057,Active,,,19.2329,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1046,743086,3,1,,144210888,11057,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1047,743091,2,1,,144204635,11057,Inconclusive,348019627.0,2099.0,5.9557199999999995,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1048,743091,2,1,,144208960,11057,Active,348019627.0,2099.0,2.8777,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1049,743091,2,1,,144210888,11057,Active,348019627.0,2099.0,3.18365,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1050,743094,3,1,,144204635,11057,Active,216409692.0,5468.0,8.4852,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1051,743094,3,1,,144208960,11057,Inconclusive,216409692.0,5468.0,43.433,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1052,743094,3,1,,144210888,11057,Inconclusive,216409692.0,5468.0,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1053,743122,2,1,,144204635,11057,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1054,743122,2,1,,144208960,11057,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1055,743122,2,1,,144210888,11057,Active,51095037.0,196.0,2.7306,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1056,743139,2,1,,144204635,11057,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1057,743139,2,1,,144208960,11057,Active,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1058,743139,2,1,,144210888,11057,Active,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1059,743140,2,1,,144204635,11057,Active,216409692.0,5468.0,8.48517,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1060,743140,2,1,,144208960,11057,Active,216409692.0,5468.0,10.9099,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1061,743140,2,1,,144210888,11057,Active,216409692.0,5468.0,10.9622,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1062,743191,3,1,,144208960,11057,Inconclusive,216409692.0,5468.0,38.7097,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1063,743191,3,1,,144210888,11057,Inconclusive,216409692.0,5468.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1064,743191,3,1,,170464787,11057,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1065,743194,3,1,,144208960,11057,Active,,,1.9401,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1066,743194,3,1,,144210888,11057,Active,,,1.9494,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1067,743194,3,1,,170464787,11057,Active,,,5.9553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1068,743199,2,1,,144208960,11057,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1069,743199,2,1,,144210888,11057,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1070,743199,2,1,,170464787,11057,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1071,743202,4,1,,144208960,11057,Inconclusive,20149576.0,4780.0,17.1414,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1072,743202,4,1,,144210888,11057,Inconclusive,20149576.0,4780.0,19.3312,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1073,743202,4,1,,170464787,11057,Inconclusive,20149576.0,4780.0,13.3322,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1074,743203,3,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1075,743203,3,1,,144210888,11057,Active,,,10.8707,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1076,743203,3,1,,170464787,11057,Active,,,11.8823,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1077,743209,3,1,,144208960,11057,Active,,,1.7291,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1078,743209,3,1,,144210888,11057,Active,,,4.3641,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1079,743209,3,1,,170464787,11057,Active,,,6.6819,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1080,743210,4,1,,144208960,11057,Inconclusive,4504517.0,3315.0,15.4106,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1081,743210,4,1,,144210888,11057,Inconclusive,4504517.0,3315.0,24.5412,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1082,743210,4,1,,170464787,11057,Inconclusive,4504517.0,3315.0,23.7083,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1083,743211,3,1,,144208960,11057,Active,,,6.8837,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1084,743211,3,1,,144210888,11057,Active,,,7.7606,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1085,743211,3,1,,170464787,11057,Active,,,8.412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1086,743212,3,1,,144208960,11057,Inconclusive,216409690.0,5467.0,38.7097,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1087,743212,3,1,,144210888,11057,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1088,743212,3,1,,170464787,11057,Inconclusive,216409690.0,5467.0,8.412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1089,743213,3,1,,144208960,11057,Active,,,17.291,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1090,743213,3,1,,144210888,11057,Active,,,17.3739,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1091,743213,3,1,,170464787,11057,Active,,,6.6819,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1092,743215,3,1,,144208960,11057,Inconclusive,216409690.0,5467.0,54.6789,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1093,743215,3,1,,144210888,11057,Inconclusive,216409690.0,5467.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1094,743215,3,1,,170464787,11057,Inconclusive,216409690.0,5467.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1095,743217,3,1,,144208960,11057,Inconclusive,325495553.0,9971.0,61.3508,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1096,743217,3,1,,144210888,11057,Inconclusive,325495553.0,9971.0,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1097,743217,3,1,,170464787,11057,Active,325495553.0,9971.0,16.7842,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1098,743218,3,1,,144208960,11057,Active,,,10.9099,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1099,743218,3,1,,144210888,11057,Active,,,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1100,743218,3,1,,170464787,11057,Active,,,10.5901,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1101,743219,3,1,,144208960,11057,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1102,743219,3,1,,144210888,11057,Active,20149576.0,4780.0,2.00875,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1103,743219,3,1,,170464787,11057,Inconclusive,20149576.0,4780.0,4.216,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1104,743220,3,1,,144208960,11057,Inconclusive,325495553.0,9971.0,48.7327,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1105,743220,3,1,,144210888,11057,Inconclusive,325495553.0,9971.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1106,743220,3,1,,170464787,11057,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1107,743221,3,1,,144208960,11057,Active,,,21.7681,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1108,743221,3,1,,144210888,11057,Active,,,27.5357,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1109,743221,3,1,,170464787,11057,Active,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1110,743222,3,1,,144208960,11057,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1111,743222,3,1,,144210888,11057,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1112,743222,3,1,,170464787,11057,Inconclusive,216409708.0,7421.0,29.846999999999998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1113,743223,3,1,,144208960,11057,Inconclusive,216409708.0,7421.0,21.7681,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1114,743223,3,1,,144210888,11057,Inconclusive,216409708.0,7421.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1115,743223,3,1,,170464787,11057,Inconclusive,216409708.0,7421.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1116,743224,3,1,,144208960,11057,Active,,,4.8733,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1117,743224,3,1,,144210888,11057,Active,,,4.8966,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1118,743224,3,1,,170464787,11057,Active,,,11.8823,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1119,743225,3,1,,144208960,11057,Active,,,9.7234,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1120,743225,3,1,,144210888,11057,Active,,,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1121,743225,3,1,,170464787,11057,Active,,,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1122,743226,2,1,,144208960,11057,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1123,743226,2,1,,144210888,11057,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1124,743226,2,1,,170464787,11057,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1125,743227,2,1,,144208960,11057,Inconclusive,216409690.0,5467.0,46.0066,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1126,743227,2,1,,144210888,11057,Inconclusive,216409690.0,5467.0,41.9981,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1127,743227,2,1,,170464787,11057,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1128,743228,3,1,,144208960,11057,Active,4504517.0,3315.0,13.2176,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1129,743228,3,1,,144210888,11057,Active,4504517.0,3315.0,5.4941,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1130,743228,3,1,,170464787,11057,Active,4504517.0,3315.0,12.5864,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1131,743239,2,1,,144208960,11057,Inconclusive,325495553.0,9971.0,59.041000000000004,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1132,743239,2,1,,144210888,11057,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1133,743239,2,1,,170464787,11057,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1134,743240,2,1,,144208960,11057,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1135,743240,2,1,,144210888,11057,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1136,743240,2,1,,170464787,11057,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1137,743241,2,1,,144208960,11057,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1138,743241,2,1,,144210888,11057,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1139,743241,2,1,,170464787,11057,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1140,743242,2,1,,144208960,11057,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1141,743242,2,1,,144210888,11057,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1142,743242,2,1,,170464787,11057,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1143,743244,1,1,,144204635,11057,Active,,,7.0795,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1144,743288,1,1,,17389869,11057,Active,,,11.2202,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1145,743288,1,1,,144204635,11057,Active,,,14.1254,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1146,743292,1,1,,17389869,11057,Active,,,35.4813,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1147,743292,1,1,,144204635,11057,Active,,,25.1189,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1148,928815,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020819,Other,,
1149,928816,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020819,Other,,
1150,928817,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020819,Other,,
1151,928818,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020819,Other,,
1152,928819,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020819,Other,,
1153,928820,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020819,Other,,
1154,928821,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020819,Other,,
1155,928822,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020819,Other,,
1156,928823,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020819,Other,,
1157,928824,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020819,Other,,
1158,928825,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020819,Other,,
1159,928826,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020819,Other,,
1160,928827,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020819,Other,,
1161,928828,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020819",Other,,
1162,928829,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020819,Other,,
1163,928830,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020819,Other,,
1164,928831,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020819,Other,,
1165,928832,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020819,Other,,
1166,928833,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020819,Other,,
1167,928869,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020819,Other,,
1168,928870,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020819,Other,,
1169,928871,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020819,Other,,
1170,928872,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020819,Other,,
1171,928873,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020819,Other,,
1172,928874,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020819,Other,,
1173,928875,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020819,Other,,
1174,928876,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020819,Other,,
1175,928877,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020819,Other,,
1176,929506,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020819,Other,,
1177,929507,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020819,Other,,
1178,929508,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020819,Other,,
1179,929509,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020819,Other,,
1180,929510,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020819,Other,,
1181,929511,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020819",Other,,
1182,929512,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020819,Other,,
1183,929513,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020819,Other,,
1184,929514,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020819,Other,,
1185,929515,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020819,Other,,
1186,962997,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020819,Other,,
1187,962998,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020819,Other,,
1188,962999,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020819,Other,,
1189,963352,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020819,Other,,
1190,963353,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020819,Other,,
1191,963354,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020819,Other,,
1192,968395,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020819,Other,,
1193,968396,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020819,Other,,
1194,968397,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020819,Other,,
1195,969029,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020819,Other,,
1196,969030,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020819,Other,,
1197,969031,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020819,Other,,
1198,969032,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020819,Other,,
1199,969033,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020819,Other,,
1200,969836,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020819,Other,,
1201,969837,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020819,Other,,
1202,969838,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020819,Other,,
1203,969839,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020819,Other,,
1204,969840,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020819,Other,,
1205,969841,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020819,Other,,
1206,969842,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020819,Other,,
1207,969843,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020819,Other,,
1208,969844,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020819,Other,,
1209,969845,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020819,Other,,
1210,969846,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020819,Other,,
1211,969847,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020819,Other,,
1212,969848,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020819,Other,,
1213,969849,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020819,Other,,
1214,969850,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020819,Other,,
1215,969851,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020819,Other,,
1216,977079,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020819,Other,,
1217,977080,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020819,Other,,
1218,977081,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020819,Other,,
1219,977082,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020819,Other,,
1220,977083,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020819,Other,,
1221,977084,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020819,Other,,
1222,977085,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020819,Other,,
1223,977086,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020819,Other,,
1224,977599,1,1,,103254526,11057,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1225,977602,1,2,,103254526,11057,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1226,1009607,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S020819",Other,,
1227,1009608,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S020819,Other,,
1228,1009609,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020819",Other,,
1229,1009610,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S020819",Other,,
1230,1009611,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Inflammation, Subacute; Study_ID: S020819",Other,,
1231,1010193,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Urothelial Hyperplasia; Study_ID: S020819",Other,,
1232,1010194,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S020819",Other,,
1233,1010195,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S020819",Other,,
1234,1010196,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020819",Other,,
1235,1010197,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S020819",Other,,
1236,1010198,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S020819",Other,,
1237,1010199,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Deposit; Study_ID: S020819",Other,,
1238,1010200,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Hyaline Droplets; Study_ID: S020819",Other,,
1239,1010201,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Necrosis; Study_ID: S020819",Other,,
1240,1010202,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Cyst(S); Study_ID: S020819",Other,,
1241,1010203,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S020819",Other,,
1242,1010204,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S020819,Other,,
1243,1010205,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S020819",Other,,
1244,1010206,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S020819",Other,,
1245,1010207,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S020819",Other,,
1246,1010208,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Cyst(S); Study_ID: S020819",Other,,
1247,1010209,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Regeneration; Study_ID: S020819",Other,,
1248,1010210,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S020819,Other,,
1249,1010211,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1250,1010212,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S020819",Other,,
1251,1010213,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S020819",Other,,
1252,1010214,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1253,1010215,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1254,1010216,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S020819",Other,,
1255,1010217,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Cast, Proteinaceous; Study_ID: S020819",Other,,
1256,1012039,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S020819",Other,,
1257,1012040,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S020819",Other,,
1258,1012041,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S020819",Other,,
1259,1012042,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1260,1012043,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S020819",Other,,
1261,1012044,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S020819",Other,,
1262,1012045,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S020819",Other,,
1263,1012046,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020819",Other,,
1264,1012047,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Tubule, Dilatation; Study_ID: S020819",Other,,
1265,1012048,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Nephropathy; Study_ID: S020819,Other,,
1266,1012049,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020819",Other,,
1267,1012050,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S020819",Other,,
1268,1012051,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S020819",Other,,
1269,1012052,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020819",Other,,
1270,1012053,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S020819",Other,,
1271,1012054,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S020819",Other,,
1272,1012055,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S020819",Other,,
1273,1012056,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S020819",Other,,
1274,1012057,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S020819",Other,,
1275,1012641,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S020819",Other,,
1276,1012642,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S020819",Other,,
1277,1012643,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Inflammation, Chronic; Study_ID: S020819",Other,,
1278,1012644,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Mineralization; Study_ID: S020819",Other,,
1279,1012645,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Necrosis; Study_ID: S020819",Other,,
1280,1012646,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S020819,Other,,
1281,1012647,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S020819,Other,,
1282,1012648,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S020819",Other,,
1283,1012649,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020819",Other,,
1284,1012650,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020819",Other,,
1285,1012651,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S020819",Other,,
1286,1012652,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Vacuolation; Study_ID: S020819",Other,,
1287,1012653,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Fibrosis; Study_ID: S020819",Other,,
1288,1012654,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Mineralization; Study_ID: S020819",Other,,
1289,1012655,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Cyst(S); Study_ID: S020819",Other,,
1290,1012656,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Dilatation; Study_ID: S020819",Other,,
1291,1012657,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S020819,Other,,
1292,1012658,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Dilatation; Study_ID: S020819",Other,,
1293,1012659,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020819",Other,,
1294,1012660,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S020819",Other,,
1295,1012661,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1296,1014494,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Autolysis; Study_ID: S020819,Other,,
1297,1014495,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020819",Other,,
1298,1014496,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S020819",Other,,
1299,1014497,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S020819",Other,,
1300,1014498,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S020819",Other,,
1301,1014499,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S020819",Other,,
1302,1014500,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Polymorphonuclear Cell; Study_ID: S020819",Other,,
1303,1014501,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Mononuclear Cell; Study_ID: S020819",Other,,
1304,1014502,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Mineralization; Study_ID: S020819",Other,,
1305,1015086,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Tubule, Regeneration; Study_ID: S020819",Other,,
1306,1015087,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S020819,Other,,
1307,1015088,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S020819",Other,,
1308,1015089,1,3,,103254526,11057,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S020819,Other,,
1309,1015090,1,3,,103254526,11057,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: subcutaneous | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S020819",Other,,
1310,1117298,1,2,,170464787,11057,Inactive,,,14.1254,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1311,1117304,1,2,,170464787,11057,Active,,,5.0119,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1312,1117305,1,2,,170464787,11057,Active,,,3.5481,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1313,1117310,1,1,,170464787,11057,Inactive,,,14.1254,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1314,1117312,1,1,,170464787,11057,Active,,,3.5481300000000005,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1315,1117314,1,1,,170464787,11057,Inactive,,,5.01187,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1316,1117322,1,1,,170464787,11057,Active,,,0.9941,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
1317,1117323,1,1,,170464787,11057,Active,,,0.3939,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
1318,1117324,1,1,,170464787,11057,Active,,,1.82716,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
1319,1117326,1,1,,170464787,11057,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1320,1117329,1,1,,170464787,11057,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1321,1117330,1,1,,170464787,11057,Active,,,0.4665,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
1322,1117332,1,1,,170464787,11057,Active,,,0.5137,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1323,1117334,1,1,,170464787,11057,Active,,,2.0496,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
1324,1117336,1,1,,170464787,11057,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1325,1117337,1,1,,170464787,11057,Active,,,0.1859,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
1326,1117338,1,1,,170464787,11057,Active,,,0.5281,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
1327,1117340,1,1,,170464787,11057,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1328,1117341,1,1,,170464787,11057,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1329,1117342,1,1,,170464787,11057,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1330,1117343,1,1,,170464787,11057,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1331,1117346,1,1,,170464787,11057,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1332,1117352,1,1,,170464787,11057,Active,,,0.4706,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
1333,1154400,1,1,,103254526,11057,Active,,,0.48,LC50,Cytotoxicity against BALB/c mouse peritoneal macrophages after 72 hrs by AlamarBlue assay,Confirmatory,24871307.0,
1334,1159509,1,1,,144208960,11057,Inconclusive,119626539.0,4790.0,48.7327,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1335,1159509,1,1,,144210888,11057,Inconclusive,119626539.0,4790.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1336,1159509,1,1,,170464787,11057,Inconclusive,119626539.0,4790.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1337,1159515,1,1,,144208960,11057,Active,,,24.4242,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1338,1159515,1,1,,144210888,11057,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1339,1159515,1,1,,170464787,11057,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1340,1159516,1,1,,144208960,11057,Inconclusive,119611100.0,22926.0,38.7097,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1341,1159516,1,1,,144210888,11057,Inconclusive,119611100.0,22926.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1342,1159516,1,1,,170464787,11057,Inconclusive,119611100.0,22926.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1343,1159517,1,1,,144208960,11057,Inconclusive,,,12.2411,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1344,1159517,1,1,,144210888,11057,Active,,,12.2998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1345,1159517,1,1,,170464787,11057,Active,,,9.5205,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1346,1159518,1,1,,144208960,11057,Inconclusive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1347,1159518,1,1,,144210888,11057,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1348,1159518,1,1,,170464787,11057,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1349,1159519,1,1,,144208960,11057,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1350,1159519,1,1,,144210888,11057,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1351,1159519,1,1,,170464787,11057,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1352,1159520,1,1,,144208960,11057,Active,,,6.082000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1353,1159520,1,1,,144210888,11057,Active,,,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1354,1159520,1,1,,170464787,11057,Active,,,5.308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1355,1159521,1,1,,144208960,11057,Active,15928672.0,19885.0,1.3616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1356,1159521,1,1,,144210888,11057,Active,15928672.0,19885.0,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1357,1159521,1,1,,170464787,11057,Active,15928672.0,19885.0,2.6603,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1358,1159523,1,1,,144208960,11057,Active,15928672.0,19885.0,1.68156,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1359,1159523,1,1,,144210888,11057,Active,15928672.0,19885.0,2.34203,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1360,1159523,1,1,,170464787,11057,Inconclusive,15928672.0,19885.0,2.4637700000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1361,1159524,1,1,,26748060,11057,Active,,,17.7828,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1362,1159525,1,1,,144208960,11057,Inconclusive,,,17.291,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1363,1159525,1,1,,144210888,11057,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1364,1159525,1,1,,170464787,11057,Inconclusive,,,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1365,1159526,1,1,,144208960,11057,Inconclusive,119627033.0,3725.0,13.7347,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1366,1159526,1,1,,144210888,11057,Inconclusive,119627033.0,3725.0,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1367,1159526,1,1,,170464787,11057,Inconclusive,119627033.0,3725.0,15.089,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1368,1159527,1,1,,144208960,11057,Inconclusive,325495497.0,6256.0,24.4242,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1369,1159527,1,1,,144210888,11057,Inconclusive,325495497.0,6256.0,0.6164,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1370,1159527,1,1,,170464787,11057,Inconclusive,325495497.0,6256.0,0.3011,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1371,1159528,1,1,,144208960,11057,Active,119627033.0,3725.0,12.2411,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1372,1159528,1,1,,144210888,11057,Active,119627033.0,3725.0,20.6489,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1373,1159528,1,1,,170464787,11057,Active,119627033.0,3725.0,11.5344,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1374,1159529,1,1,,144208960,11057,Active,,,13.7347,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1375,1159529,1,1,,144210888,11057,Active,,,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1376,1159529,1,1,,170464787,11057,Active,,,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1377,1159531,1,1,,144208960,11057,Inconclusive,325495497.0,6256.0,1.15563,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1378,1159531,1,1,,144210888,11057,Inconclusive,325495497.0,6256.0,0.570904,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1379,1159531,1,1,,170464787,11057,Inconclusive,325495497.0,6256.0,1.26958,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1380,1159550,3,1,,252401313,11057,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1381,1159551,1,1,,144208960,11057,Active,,,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1382,1159551,1,1,,144210888,11057,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1383,1159551,1,1,,170464787,11057,Active,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1384,1159552,1,1,,144208960,11057,Active,325495463.0,5914.0,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1385,1159552,1,1,,144210888,11057,Active,325495463.0,5914.0,2.169,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1386,1159552,1,1,,170464787,11057,Active,325495463.0,5914.0,3.7578,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1387,1159553,2,1,,144208960,11057,Inconclusive,325495463.0,5914.0,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1388,1159553,2,1,,144210888,11057,Inconclusive,325495463.0,5914.0,0.9689,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1389,1159553,2,1,,170464787,11057,Inconclusive,325495463.0,5914.0,2.9849,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1390,1159555,1,1,,144208960,11057,Inconclusive,325495463.0,5914.0,6.4423699999999995,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1391,1159555,1,1,,144210888,11057,Active,325495463.0,5914.0,2.7306,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1392,1159555,1,1,,170464787,11057,Active,325495463.0,5914.0,4.21632,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1393,1159614,1,2,,170464787,11057,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1394,1159620,1,1,,103254526,11057,Active,,,,,Summary of drug indications.,Other,,
1395,1164929,1,1,,103254526,11057,Unspecified,,,,,Trypanocidal activity against epimastigote forms of Trypanosoma cruzi Punta Lobos after 24 hrs,Other,25238291.0,
1396,1164930,1,1,,103254526,11057,Unspecified,,,,,Trypanocidal activity against epimastigote forms of Trypanosoma cruzi Queretaro after 24 hrs,Other,25238291.0,
1397,1224834,3,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1398,1224834,3,1,,144210888,11057,Active,,,12.1972,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1399,1224834,3,1,,170464787,11057,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1400,1224835,1,1,,144208960,11057,Active,160794.0,,17.7421,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1401,1224835,1,1,,144210888,11057,Active,160794.0,,35.5742,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1402,1224835,1,1,,170464787,11057,Active,160794.0,,17.3768,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1403,1224836,1,1,,144208960,11057,Active,,,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1404,1224836,1,1,,144210888,11057,Active,,,6.859,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1405,1224836,1,1,,170464787,11057,Active,,,5.9557,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1406,1224837,1,1,,144208960,11057,Active,,,8.591000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1407,1224837,1,1,,144210888,11057,Active,,,7.6959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1408,1224837,1,1,,170464787,11057,Active,,,5.308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1409,1224838,1,1,,144208960,11057,Active,66775687.0,9970.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1410,1224838,1,1,,144210888,11057,Active,66775687.0,9970.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1411,1224838,1,1,,170464787,11057,Active,66775687.0,9970.0,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1412,1224839,1,1,,144208960,11057,Inactive,66775687.0,9970.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1413,1224839,1,1,,144210888,11057,Inactive,66775687.0,9970.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1414,1224839,1,1,,170464787,11057,Inactive,66775687.0,9970.0,14.9601,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1415,1224840,3,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1416,1224840,3,1,,144210888,11057,Active,,,4.3277,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1417,1224840,3,1,,170464787,11057,Active,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1418,1224841,3,1,,144208960,11057,Active,325495545.0,2101.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1419,1224841,3,1,,144210888,11057,Inconclusive,325495545.0,2101.0,0.5448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1420,1224841,3,1,,170464787,11057,Active,325495545.0,2101.0,1.1883,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1421,1224842,3,1,,144208960,11057,Inactive,325495545.0,2101.0,0.6082,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1422,1224842,3,1,,144210888,11057,Inactive,325495545.0,2101.0,0.6113,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1423,1224842,3,1,,170464787,11057,Inactive,325495545.0,2101.0,1.0591,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1424,1224843,1,1,,144208960,11057,Inconclusive,119601739.0,7253.0,21.5797,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1425,1224843,1,1,,144210888,11057,Inconclusive,119601739.0,7253.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1426,1224843,1,1,,170464787,11057,Inconclusive,119601739.0,7253.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1427,1224844,1,1,,144208960,11057,Active,,,19.4008,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1428,1224844,1,1,,144210888,11057,Active,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1429,1224844,1,1,,170464787,11057,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1430,1224845,1,1,,144208960,11057,Inconclusive,344243002.0,100757539.0,17.8227,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1431,1224845,1,1,,144210888,11057,Inconclusive,344243002.0,100757539.0,44.9878,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1432,1224845,1,1,,170464787,11057,Inconclusive,344243002.0,100757539.0,19.5845,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1433,1224846,1,1,,144208960,11057,Inconclusive,11995455.0,3091.0,21.7681,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1434,1224846,1,1,,144210888,11057,Inconclusive,11995455.0,3091.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1435,1224846,1,1,,170464787,11057,Inconclusive,11995455.0,3091.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1436,1224847,1,1,,144208960,11057,Active,,,3.1694,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1437,1224847,1,1,,144210888,11057,Active,,,12.6793,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1438,1224847,1,1,,170464787,11057,Active,,,13.8647,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1439,1224848,3,1,,144208960,11057,Active,325495545.0,2101.0,0.6824,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1440,1224848,3,1,,144210888,11057,Active,325495545.0,2101.0,0.8635,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1441,1224848,3,1,,170464787,11057,Active,325495545.0,2101.0,1.3333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1442,1224849,3,1,,144208960,11057,Inactive,325495545.0,2101.0,0.6082,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1443,1224849,3,1,,144210888,11057,Inactive,325495545.0,2101.0,0.9689,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1444,1224849,3,1,,170464787,11057,Inactive,325495545.0,2101.0,1.3333,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1445,1224857,2,1,,170464787,11057,Inactive,,,7.0795,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1446,1224859,2,1,,170464787,11057,Inactive,,,35.4813,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1447,1224867,1,1,,144208960,11057,Active,,,24.4242,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1448,1224867,1,1,,144210888,11057,Active,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1449,1224867,1,1,,170464787,11057,Active,,,10.6822,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1450,1224868,1,1,,144208960,11057,Active,,,2.7404,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1451,1224868,1,1,,144210888,11057,Active,,,6.9167,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1452,1224868,1,1,,170464787,11057,Active,,,2.3914,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1453,1224869,1,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1454,1224869,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1455,1224869,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1456,1224870,1,1,,144208960,11057,Active,,,34.5001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1457,1224870,1,1,,144210888,11057,Active,,,43.6412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1458,1224870,1,1,,170464787,11057,Active,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1459,1224871,1,1,,144208960,11057,Inconclusive,,,19.4008,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1460,1224871,1,1,,144210888,11057,Active,,,21.8724,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1461,1224871,1,1,,170464787,11057,Active,,,21.3138,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1462,1224872,1,1,,144208960,11057,Active,,,6.8837,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1463,1224872,1,1,,144210888,11057,Active,,,19.4938,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1464,1224872,1,1,,170464787,11057,Active,,,7.5624,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1465,1224873,1,1,,144208960,11057,Active,,,19.4008,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1466,1224873,1,1,,144210888,11057,Active,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1467,1224873,1,1,,170464787,11057,Inconclusive,,,16.9301,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1468,1224874,1,1,,144208960,11057,Active,,,1.7291,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1469,1224874,1,1,,144210888,11057,Active,,,4.8966,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1470,1224874,1,1,,170464787,11057,Active,,,1.693,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1471,1224875,1,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1472,1224875,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1473,1224875,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1474,1224876,1,1,,144208960,11057,Active,,,10.9099,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1475,1224876,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1476,1224876,1,1,,170464787,11057,Inconclusive,,,15.089,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1477,1224877,1,1,,144208960,11057,Active,,,30.7482,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1478,1224877,1,1,,144210888,11057,Active,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1479,1224877,1,1,,170464787,11057,Active,,,21.3138,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1480,1224878,1,1,,144208960,11057,Active,,,10.9099,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1481,1224878,1,1,,144210888,11057,Active,,,12.2998,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1482,1224878,1,1,,170464787,11057,Active,,,18.9959,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1483,1224879,1,1,,144208960,11057,Active,,,10.9099,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1484,1224879,1,1,,144210888,11057,Active,,,12.2998,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1485,1224879,1,1,,170464787,11057,Active,,,21.3138,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1486,1224880,1,1,,144208960,11057,Inconclusive,,,1.9401,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1487,1224880,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1488,1224880,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1489,1224881,1,1,,144208960,11057,Inconclusive,,,19.4008,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1490,1224881,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1491,1224881,1,1,,170464787,11057,Inconclusive,,,10.6822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1492,1224882,1,1,,144208960,11057,Inactive,,,30.7482,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1493,1224882,1,1,,144210888,11057,Inactive,,,21.8724,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1494,1224882,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1495,1224883,1,1,,144208960,11057,Active,,,10.9099,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1496,1224883,1,1,,144210888,11057,Active,,,10.9622,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1497,1224883,1,1,,170464787,11057,Active,,,18.9959,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1498,1224884,1,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1499,1224884,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1500,1224884,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1501,1224885,1,1,,144208960,11057,Active,,,21.7681,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1502,1224885,1,1,,144210888,11057,Active,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1503,1224885,1,1,,170464787,11057,Inconclusive,,,10.6822,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1504,1224886,1,1,,144208960,11057,Active,,,5.4679,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1505,1224886,1,1,,144210888,11057,Active,,,7.7606,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1506,1224886,1,1,,170464787,11057,Active,,,3.0107,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1507,1224887,1,1,,144208960,11057,Active,,,21.7681,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1508,1224887,1,1,,144210888,11057,Active,,,43.6412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1509,1224887,1,1,,170464787,11057,Inconclusive,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1510,1224888,1,1,,144208960,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1511,1224888,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1512,1224888,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1513,1224889,1,1,,144208960,11057,Inconclusive,,,38.7097,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1514,1224889,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1515,1224889,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1516,1224890,1,1,,144208960,11057,Inconclusive,,,15.4106,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1517,1224890,1,1,,144210888,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1518,1224890,1,1,,170464787,11057,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1519,1224892,1,1,,144208960,11057,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1520,1224892,1,1,,144210888,11057,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1521,1224892,1,1,,170464787,11057,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1522,1224893,1,1,,144208960,11057,Inconclusive,66775687.0,9970.0,22.8584,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1523,1224893,1,1,,144210888,11057,Inconclusive,66775687.0,9970.0,21.6899,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1524,1224893,1,1,,170464787,11057,Inconclusive,66775687.0,9970.0,22.8175,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1525,1224894,1,1,,144208960,11057,Inconclusive,11995455.0,3091.0,26.8836,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1526,1224894,1,1,,144210888,11057,Inconclusive,11995455.0,3091.0,48.9662,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1527,1224894,1,1,,170464787,11057,Inconclusive,11995455.0,3091.0,26.8325,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1528,1224895,1,1,,144208960,11057,Inconclusive,119601739.0,7253.0,56.3264,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1529,1224895,1,1,,144210888,11057,Inconclusive,119601739.0,7253.0,54.4827,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1530,1224895,1,1,,170464787,11057,Inconclusive,119601739.0,7253.0,28.7255,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1531,1224896,1,1,,144208960,11057,Active,344243002.0,100757539.0,15.2864,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1532,1224896,1,1,,144210888,11057,Active,344243002.0,100757539.0,20.0953,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1533,1224896,1,1,,170464787,11057,Active,344243002.0,100757539.0,27.6638,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1534,1254435,1,1,,103254526,11057,Inconclusive,,,,IC50,Antiparasitic activity against bloodstream trypomastigote stage of Trypanosoma cruzi Y assessed as parasite viability after 24 hrs by Neubauer chamber analysis,Confirmatory,26549870.0,
1535,1254436,1,1,,103254526,11057,Active,,,0.45,CC50,Cytotoxicity against mouse J774 cells assessed as cell viability after 72 hrs by Alamar Blue assay,Confirmatory,26549870.0,
1536,1254437,1,1,,103254526,11057,Inconclusive,,,,,"Selectivity index, ratio of CC50 for human J774 cells to IC50 for bloodstream trypomastigote stage of Trypanosoma cruzi Y",Other,26549870.0,
1537,1259241,1,1,,144208960,11057,Active,,,8.591000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1538,1259241,1,1,,144210888,11057,Active,,,6.859,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1539,1259241,1,1,,170464787,11057,Active,,,5.308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1540,1259242,1,1,,144208960,11057,Active,,,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1541,1259242,1,1,,144210888,11057,Active,,,6.859,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1542,1259242,1,1,,170464787,11057,Active,,,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1543,1259243,1,1,,144208960,11057,Active,124375976.0,367.0,1.5277,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1544,1259243,1,1,,144210888,11057,Active,124375976.0,367.0,3.4376,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1545,1259243,1,1,,170464787,11057,Active,124375976.0,367.0,1.8834,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1546,1259244,1,1,,144208960,11057,Active,348019627.0,2099.0,1.7141,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1547,1259244,1,1,,144210888,11057,Active,348019627.0,2099.0,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1548,1259244,1,1,,170464787,11057,Active,348019627.0,2099.0,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1549,1259247,1,1,,144208960,11057,Active,124375976.0,367.0,1.6496,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1550,1259247,1,1,,144210888,11057,Inconclusive,124375976.0,367.0,3.43762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1551,1259247,1,1,,170464787,11057,Inconclusive,124375976.0,367.0,1.88336,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1552,1259248,1,1,,144208960,11057,Active,348019627.0,2099.0,2.66509,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1553,1259248,1,1,,144210888,11057,Inconclusive,348019627.0,2099.0,4.16478,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1554,1259248,1,1,,170464787,11057,Inconclusive,348019627.0,2099.0,2.87255,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1555,1259310,1,1,,321948874,11057,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1556,1259344,1,1,,144204635,11057,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1557,1259355,1,1,,144204635,11057,Active,,,22.3872,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1558,1259356,1,1,,144204635,11057,Active,,,7.3048,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1559,1259364,1,1,,144208960,11057,Active,1013403374.0,9734.0,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1560,1259364,1,1,,144210888,11057,Active,1013403374.0,9734.0,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1561,1259364,1,1,,170464787,11057,Active,1013403374.0,9734.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1562,1259365,1,1,,144208960,11057,Active,,,13.6159,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1563,1259365,1,1,,144210888,11057,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1564,1259365,1,1,,170464787,11057,Active,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1565,1259366,1,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1566,1259366,1,1,,144210888,11057,Active,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1567,1259366,1,1,,170464787,11057,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1568,1259367,1,1,,144208960,11057,Active,,,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1569,1259367,1,1,,144210888,11057,Active,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1570,1259367,1,1,,170464787,11057,Active,,,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1571,1259368,1,1,,144208960,11057,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1572,1259368,1,1,,144210888,11057,Inactive,109731339.0,2737.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1573,1259368,1,1,,170464787,11057,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1574,1259369,1,1,,144208960,11057,Active,109731339.0,2737.0,1.5277,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1575,1259369,1,1,,144210888,11057,Active,109731339.0,2737.0,0.8635,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1576,1259369,1,1,,170464787,11057,Active,109731339.0,2737.0,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1577,1259377,1,1,,144208960,11057,Inconclusive,54288833.0,2100.0,12.1352,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1578,1259377,1,1,,144210888,11057,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1579,1259377,1,1,,170464787,11057,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1580,1259378,1,1,,144208960,11057,Active,54288833.0,2100.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1581,1259378,1,1,,144210888,11057,Inconclusive,54288833.0,2100.0,76.9588,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1582,1259378,1,1,,170464787,11057,Active,54288833.0,2100.0,37.578,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1583,1259379,1,1,,144208960,11057,Active,,,4.3057,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1584,1259379,1,1,,144210888,11057,Active,,,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1585,1259379,1,1,,170464787,11057,Active,,,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1586,1259380,1,1,,144208960,11057,Active,,,10.8155,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1587,1259380,1,1,,144210888,11057,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1588,1259380,1,1,,170464787,11057,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1589,1259381,1,1,,144208960,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1590,1259381,1,1,,144210888,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1591,1259381,1,1,,170464787,11057,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1592,1259382,1,1,,144208960,11057,Active,,,21.5797,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1593,1259382,1,1,,144210888,11057,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1594,1259382,1,1,,170464787,11057,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1595,1259383,1,1,,144208960,11057,Inactive,348019627.0,2099.0,6.8241,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1596,1259383,1,1,,144210888,11057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1597,1259383,1,1,,170464787,11057,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1598,1259384,1,1,,144208960,11057,Inconclusive,,,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1599,1259384,1,1,,144210888,11057,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1600,1259384,1,1,,170464787,11057,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1601,1259385,1,1,,144208960,11057,Inconclusive,119601739.0,7253.0,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1602,1259385,1,1,,144210888,11057,Inconclusive,119601739.0,7253.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1603,1259385,1,1,,170464787,11057,Inconclusive,119601739.0,7253.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1604,1259386,1,1,,144208960,11057,Active,,,8.591000000000001,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1605,1259386,1,1,,144210888,11057,Active,,,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1606,1259386,1,1,,170464787,11057,Active,,,5.9557,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1607,1259387,1,1,,144208960,11057,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1608,1259387,1,1,,144210888,11057,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1609,1259387,1,1,,170464787,11057,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1610,1259388,1,1,,144208960,11057,Inconclusive,1013403374.0,9734.0,17.1414,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1611,1259388,1,1,,144210888,11057,Inconclusive,1013403374.0,9734.0,17.2289,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1612,1259388,1,1,,170464787,11057,Inconclusive,1013403374.0,9734.0,12.3481,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1613,1259389,1,1,,124637593,11057,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1614,1259390,1,1,,144208960,11057,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1615,1259390,1,1,,144210888,11057,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1616,1259390,1,1,,170464787,11057,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1617,1259391,1,1,,144208960,11057,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1618,1259391,1,1,,144210888,11057,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1619,1259391,1,1,,170464787,11057,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1620,1259392,1,1,,144208960,11057,Active,109731339.0,2737.0,1.52773,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1621,1259392,1,1,,144210888,11057,Active,109731339.0,2737.0,1.7903,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1622,1259392,1,1,,170464787,11057,Active,109731339.0,2737.0,2.19584,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1623,1259393,1,1,,144208960,11057,Inconclusive,119601739.0,7253.0,47.3928,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1624,1259393,1,1,,144210888,11057,Inconclusive,119601739.0,7253.0,43.2771,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1625,1259393,1,1,,170464787,11057,Inconclusive,119601739.0,7253.0,27.644000000000002,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1626,1259394,1,1,,144208960,11057,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1627,1259394,1,1,,144210888,11057,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1628,1259394,1,1,,170464787,11057,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1629,1259395,1,1,,144208960,11057,Active,119601739.0,7253.0,53.1756,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1630,1259395,1,1,,144210888,11057,Active,119601739.0,7253.0,58.82899999999999,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1631,1259395,1,1,,170464787,11057,Active,119601739.0,7253.0,27.644000000000002,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1632,1259396,1,1,,144208960,11057,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1633,1259396,1,1,,144210888,11057,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1634,1259396,1,1,,170464787,11057,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1635,1259400,1,1,,170464787,11057,Active,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1636,1259401,1,1,,144208960,11057,Inconclusive,325495545.0,2101.0,4.0648599999999995,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1637,1259401,1,1,,144210888,11057,Active,325495545.0,2101.0,1.2197200000000001,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1638,1259401,1,1,,170464787,11057,Active,325495545.0,2101.0,0.943918,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1639,1259402,1,1,,144208960,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1640,1259402,1,1,,144210888,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1641,1259402,1,1,,170464787,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1642,1259403,1,1,,144208960,11057,Active,325495545.0,2101.0,0.826759,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1643,1259403,1,1,,144210888,11057,Active,325495545.0,2101.0,1.1296,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1644,1259403,1,1,,170464787,11057,Active,325495545.0,2101.0,0.87418,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1645,1259404,1,1,,144208960,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1646,1259404,1,1,,144210888,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1647,1259404,1,1,,170464787,11057,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1648,1259407,1,1,,363900414,11057,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1649,1259408,1,1,,363895726,11057,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
1650,1259411,1,1,,363900414,11057,Active,,,,,CCRIS carcinogenicity studies,Other,,
